These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 26429521)

  • 1. The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies.
    Sciascia S; Hunt BJ; Talavera-Garcia E; Lliso G; Khamashta MA; Cuadrado MJ
    Am J Obstet Gynecol; 2016 Feb; 214(2):273.e1-273.e8. PubMed ID: 26429521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
    Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
    Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcomes in women with rheumatic diseases: a real-world observational study in Japan.
    Sugawara E; Kato M; Fujieda Y; Oku K; Bohgaki T; Yasuda S; Umazume T; Morikawa M; Watari H; Atsumi T
    Lupus; 2019 Oct; 28(12):1407-1416. PubMed ID: 31551035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome of 126 anti-SSA/Ro-positive patients during the past 24 years--a retrospective cohort study.
    Luo Y; Zhang L; Fei Y; Li Y; Hao D; Liu Y; Zhao Y
    Clin Rheumatol; 2015 Oct; 34(10):1721-8. PubMed ID: 26384980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of 100 high risk lupus pregnancies.
    Buchanan NM; Khamashta MA; Morton KE; Kerslake S; Baguley EA; Hughes GR
    Am J Reprod Immunol; 1992; 28(3-4):192-4. PubMed ID: 1285876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases.
    Khizroeva J; Bitsadze V; Tincani A; Makatsariya A; Arslanbekova M; Babaeva N; Tsibizova V; Shkoda A; Makatsariya N; Tretyakova M; Solopova A; Gadaeva Z; Vorobev A; Khamani I; Aslanova Z; Nakaidze I; Mischenko A; Grigoreva K; Kunesko N; Egorova E; Mashkova T
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6157-6164. PubMed ID: 34044735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.
    Pattison NS; Chamley LW; Birdsall M; Zanderigo AM; Liddell HS; McDougall J
    Am J Obstet Gynecol; 2000 Oct; 183(4):1008-12. PubMed ID: 11035355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.
    Nuri E; Taraborelli M; Andreoli L; Tonello M; Gerosa M; Calligaro A; Argolini LM; Kumar R; Pengo V; Meroni PL; Ruffatti A; Tincani A
    Immunol Res; 2017 Feb; 65(1):17-24. PubMed ID: 27406736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study.
    Mekinian A; Lazzaroni MG; Kuzenko A; Alijotas-Reig J; Ruffatti A; Levy P; Canti V; Bremme K; Bezanahary H; Bertero T; Dhote R; Maurier F; Andreoli L; Benbara A; Tigazin A; Carbillon L; Nicaise-Roland P; Tincani A; Fain O;
    Autoimmun Rev; 2015 Jun; 14(6):498-502. PubMed ID: 25617818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus and pregnancy: A retrospective single-center study of 215 pregnancies from Portugal.
    Braga A; Barros T; Faria R; Marinho A; Carvalheira G; Rocha G; Farinha F; Neves E; Vasconcelos C; Braga J
    Lupus; 2021 Nov; 30(13):2165-2175. PubMed ID: 34693803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
    Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
    Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome.
    Gerde M; Ibarra E; Mac Kenzie R; Fernandez Suarez C; Heer C; Alvarez R; Iglesias M; Balparda J; Beruti E; Rubinstein F
    Thromb Res; 2021 Oct; 206():104-110. PubMed ID: 34454240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia.
    Al Arfaj AS; Khalil N
    Lupus; 2010 Dec; 19(14):1665-73. PubMed ID: 20947541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.
    Sciascia S; Branch DW; Levy RA; Middeldorp S; Pavord S; Roccatello D; Ruiz-Irastorza G; Tincani A; Khamashta M; Schreiber K; Hunt BJ
    Thromb Haemost; 2016 Jan; 115(2):285-90. PubMed ID: 26421409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study.
    Mekinian A; Alijotas-Reig J; Carrat F; Costedoat-Chalumeau N; Ruffatti A; Lazzaroni MG; Tabacco S; Maina A; Masseau A; Morel N; Esteve-Valverde EE; Ferrer-Oliveras R; Andreoli L; De Carolis S; Josselin-Mahr L; Abisror N; Nicaise-Roland P; Tincani A; Fain O;
    Autoimmun Rev; 2017 Jul; 16(7):730-734. PubMed ID: 28478081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus.
    Broder A; Putterman C
    J Rheumatol; 2013 Jan; 40(1):30-3. PubMed ID: 22859353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy.
    ; Silver R; Craigo S; Porter F; Osmundson SS; Kuller JA; Norton ME
    Am J Obstet Gynecol; 2023 Mar; 228(3):B41-B60. PubMed ID: 36084704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current insights in obstetric antiphospholipid syndrome.
    Schreiber K; Radin M; Sciascia S
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hydroxychloroquine: a new therapeutic approach to the thrombotic manifestations of antiphospholipid syndrome].
    Szymezak J; Ankri A; Fischer AM; Darnige L
    Rev Med Interne; 2010 Dec; 31(12):854-7. PubMed ID: 20888088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.